| 6.78 1.25 (22.6%) | 12-19 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 8.12 |
1-year : | 9.49  |
| Resists | First : | 6.95 |
Second : | 8.12 |
| Pivot price | 5.53 |
|||
| Supports | First : | 5.05 |
Second : | 3.88 |
| MAs | MA(5) : | 5.71 |
MA(20) : | 5.68 |
| MA(100) : | 10.58 |
MA(250) : | 0 | |
| MACD | MACD : | -0.5 |
Signal : | -0.7 |
| %K %D | K(14,3) : | 74.1 |
D(3) : | 65.5 |
| RSI | RSI(14): 55.4 |
|||
| 52-week | High : | 45.9 | Low : | 3.88 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ AGPU ] has closed It is unclear right now based on current values. 46.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 19 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 6.97 - 7 | 7 - 7.02 |
| Low: | 5.4 - 5.43 | 5.43 - 5.45 |
| Close: | 6.73 - 6.78 | 6.78 - 6.82 |
Axe Compute Inc., a knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of cancer therapies. It operates through two segments, Pittsburgh and Eagan. The Pittsburgh segment provides services that include the application of AI using its proprietary biobank of 150,000+ tumor samples. This segment also creates proprietary 3D culture models used in drug development. Its Eagan segment produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. Predictive Oncology Inc. has a strategic collaboration with Every Cure to identify and prioritize drugs for repurposing. The company was formerly known as Predictive Oncology Inc. and changed its name to Axe Compute Inc. in December 2025. Axe Compute Inc. was incorporated in 2002 and is headquartered in Pittsburgh, Pennsylvania.
Sat, 13 Dec 2025
Predictive Oncology Becomes Axe Compute, Expanding Into High-Performance AI Infrastructure - Tekedia
Fri, 12 Dec 2025
Predictive Oncology Rebrands to Axe Compute Inc. on Nasdaq - The Globe and Mail
Fri, 12 Dec 2025
Predictive Oncology announces name change to Axe Compute - TipRanks
Fri, 12 Dec 2025
Axe Compute rebrands, begins trading under NASDAQ:AGPU ticker - Investing.com
Fri, 12 Dec 2025
Axe Compute Inc. Announces Name Change and Expansion into High-Performance AI Infrastructure Services - Quiver Quantitative
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Technology
|
|
|
Industry:
Software - Infrastructure
|
|
| Shares Out | 0 (M) |
| Shares Float | 3 (M) |
| Held by Insiders | 1.83e+006 (%) |
| Held by Institutions | 4.9 (%) |
| Shares Short | 42 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -1.08e+007 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -90 % |
| Return on Assets (ttm) | 654 % |
| Return on Equity (ttm) | -128.9 % |
| Qtrly Rev. Growth | 1.66e+006 % |
| Gross Profit (p.s.) | -5.49 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 602993 |
| Qtrly Earnings Growth | -141.4 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -8 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | -0.1 |
| Dividend | 0 |
| Forward Dividend | 68790 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|